Skip to main content
. 2022 Feb;11(2):378–388. doi: 10.21037/gs-21-906

Table 6. Demographics and clinical characteristics of patients undergoing central lymph node dissection in the testing model group.

Clinicopathological properties Total Central lymph node metastasis
No, n (%) Yes, n (%)
Patient 112 54 (48.2) 58 (51.8)
Gender
   Female 91 51 (56.0) 40 (44.0)
   Male 21 3 (14.3) 18 (85.7)
Age (years)
   <45 50 21 (42.0) 29 (58.0)
   ≥45 62 33 (53.2) 29 (46.8)
Tumor size (cm)
   <1 58 41 (70.7) 17 (29.3)
   ≥1 54 13 (24.1) 41 (75.9)
Tumor location
   Upper 42 38 (90.5) 4 (9.5)
   Middle/lower 70 16 (22.9) 54 (77.1)
Ultrasound feature
   Intra-nodular vascularity
    No 45 37 (82.2) 8 (17.8)
    Yes 67 17 (25.4) 50 (74.6)
   Microcalcification
    No 41 30 (73.2) 11 (26.8)
    Yes 71 24 (33.8) 47 (66.2)
   Irregular shape
    No 50 42 (84.0) 8 (16.0)
    Yes 62 12 (19.4) 50 (80.4)
   Infiltrative margin
    No 38 33 (86.8) 5 (13.2)
    Yes 74 21 (28.4) 53 (71.6)
   Multifocality
    No 80 43 (53.8) 37 (46.2)
    Yes 32 11 (34.4) 21 (65.6)
   Extrathyroidal extension
    No 102 54 (52.9) 48 (47.1)
    Yes 10 0 (0.0) 10 (100.0)